Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)

British Journal of Haematology

Volumn 95, Issue 4, 1996, Pages 660-665

  Mathiot, C ^a   Mary, J Y ^b   Tartour, E ^a   Facon, T ^c   Monconduit, M ^d   Grosbois, B ^e   Pollet, J P ^f   Michaux, J L ^g   Euller Ziegler, L ^h   Sautes C ^a   Bataille, R ⁱ   Fridman, W H ^a  

^a INSTITUT CURIE   (France)

^b INSERM   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d CENTRE HENRI BECQUEREL   (France)

^e SERVICE DE RHUMATOLOGIE   (France)

^f CENTRE HOSPITALIER DE VALENCIENNES   (France)

^g UCL 1200 Bruxelles   (France)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

ⁱ INSTITUT DE BIOLOGIE   (France)

Author keywords

MGUS; multiple myeloma; sCD16; sFc RIII; sIL 6R

Indexed keywords

CD16 ANTIGEN; INTERLEUKIN 6 RECEPTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 8044242943     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1943.x     Document Type: Article

References (26)

1. Axelsson, U. (1986) A 20-year follow up study of 64 subjects with M-components. Acta Medica Scandinavica, 219, 519-522.
2. Axelsson, U., Backman, R. & Hällen, J. (1966) Frequency of pathological proteins (M-components) in 6995 sera from an adult population. Acta Medica Scandinavica, 179, 235-247.
3. Bazil, V & Strominger, J.L. (1994) Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Journal of Immunology, 152, 1314-1322.
4. Bouchard, C., Galinha, A., Tartour, E., Fridman, W.H. & Sautes, C. (1995) A transforming growth β-like immunosuppressive factor in immunoglobulin G binding factor. Journal of Experimental Medicine, 6, 1717-1726.
5. Brownie, C. Habicht, J.P. & Cogill, P. (1986) Comparing indicators of health or nutrional status. American Journal of Epidemiology, 1031-1044.
6. Cartron, J., Celton, J.L., Gane, P., Astier, A., Fridman, W.H., Boissinot, G. & Cartron, J.P. (1992) Iso-immune neonatal neutropenia due to an anti-FcRIII-1 (CD16) antibody. European Journal of Pediatrics, 151, 438-441.
7. Fine, J.M., Lamblin, P. & Muller, J.Y. (1979) The evolution of asymptomatic monoclonal gammopathies: a follow up of 20 cases over periods of 3-14 years. Acta Medica Scandinavica, 205, 339-341.
8. Fleit, H.B., Kobasiuk, C.D., Doly, C., Furie, R., Levy, P.C. & Webster, R.O. (1992) A soluble form of FcγRIII is present in human serum and other body fluids and is elevated at sites of inflammation. Blood, 79, 2721-2728.
9. Galon, J., Gauchat, J.F., Mazières, N., Spagnoli, R., Storkus, W., Lötze, M., Bonnefoy, J.Y., Fridman, W.H. & Sautès, C. (1996) Soluble FCγ receptor type III (FcγIII, CD16) triggers cell activation through interaction with complement receptors. Journal of Immunology, 157, 1184-1192.
10. Gaillard, J.P., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, M., Taga, T., Kishimoto, T. & Klein, B. (1993) Increased and highly stable levels of functional soluble interleukin-6 receptor levels in sera of patients with monoclonal gammopathy. European Journal of Immunology, 23, 820-824.
11. Greipp, Ph.R. & Kyle, R.A. (1985) Clinical, morphological and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Blood, 62, 166-171.
12. Grosbois, B., Mary, J.Y., Michaux, J.L., Facon, T., Laporte, J.P., Euller Ziegler, L., Wetterwald, M., Bauters, F. & Monconduit, M. (1993) Continuous or sequential melphalan in combination with Interferon alfa-2a (IFN α2a) and prednisone in patients with multiple myeloma: preliminary results. Blood, 82. (Suppl. 1), 263a.
13. Harrison, D., Phillips, J.H. & Lanier, L.L. (1991) Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated FcγRIII. Journal of Immunology, 147, 3459-3465.
14. Hoover, R.G., Lary, C.R., Page, R., Travis, P., Owens, R., Flick, J., Kornbluth, J. & Barlogie, B. (1995) Autoregulatory circuits in myeloma: tumour cell cytotoxicity mediated by soluble CD16. Journal of Clinical Investigation, 95, 241-247.
15. Huizinga, T.W.J., de Haas, M., Nuijens, J.H., Roos, D. & von dem Borne, A.E.G.Kr. (1990a) Soluble FcγRIII in human plasma originates from release by neutrophils. Journal of Clinical Investigation, 86, 416-423.
16. Huizinga, T.W.J., de Haas, M., van Oers, M.H.J., Kleijer, M., Vilé, H., van der Wouw, P.A., Moulijn, A., Roos, D. & von dem Borne, A.E.G.Kr. (1994) The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. British Journal of Haematology, 87, 459-463.
17. Huizinga, T.W.J., Kuijpers, R.W., Kleijer, M., Schulpen, T.W.J., Cuypers, H.T.M., Roos, D. & von dem Borne, A.E.G.Kr. (1990b) Maternal genomic neutrophil FCγRIII deficiency leading to neonatal isoimmune neutropenia. Blood, 76, 1927-1932.
18. Kyle, R.A. (1993) 'Benign' monoclonal gammopathy after 20-35 years of follow-up. Mayo Clinic Proceedings, 68, 26-36.
19. Mathiot, C., Teillaud, J.L., Elmalek, M., Mosseri, V., Euller-Ziegler, L., Daragon, A., Grosbois, B., Michaux, J.L., Facon, T., Bernard, J.F., Duclos, B., Monconduit, M. & Fridman, W.H. (1993) Correlation between serum soluble CD16 (sCD16) levels and disease stage in patients with multiple myeloma. Journal of Clinical Immunology, 13, 41-48.
20. Metz, L. (1978) Basic principles of ROC analysis. Seminars in Nuclear Medicine, 3, 283-298.
21. Mock, B.A., Krall, M.M. & Dosik, J.K. (1993) Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proceedings of the National Academy of Sciences of the United States of America, 90, 9499-9503.
22. Ravetch, J.V. & Kinet, J.P. (1991) Fc receptors. Annual Review of Immunology, 9, 457-557.
23. Siegel, S. (1956) Non-parametric Statistics for the Behavioral Sciences, pp. 202-213. McGraw Hill, New York.
24. Teillaud, C., Galon, J., Zilber, M.T., Mazieres, N., Spagnoli, R., Kurrle, R., Fridman, W.H. & Sautes, C. (1993) Soluble CD16 binds peripheral blood mononuclear cells and inhibits pokeweed-mitogen-induced responses. Blood, 82, 3081-3090.
25. Teillaud, J.L., Bouchard, C., Astier, A., Teillaud, C., Tartour, E., Michon, J., Galinha, A., Moncuit, J., Mazières, N., Spagnoli, R., Fridman, W.H. & Sautès, C. (1994) Natural and recombinant soluble low-affinity Fcγ R detection, purification and functional activities. Immunomethods, 4, 48-64.
26. Vandepoel, M.H.W., Coebergh, J.W.W. & Hillen, H.F.P. (1995) Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands. British Journal of Haematology, 91, 121-125.